沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的临床效果

Clinical effect of sakubatra valsartan combined with bisoprolol on chronic heart failure

目的探讨沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的临床效果。方法选取2017年1月至2018年8月在本院接受治疗的80例慢性心力衰竭患者作为研究对象,运用临床随机抽签分组的方式分为对照组和观察组,各40例。对照组患者运用比索洛尔进行治疗,观察组患者则在对照组患者的基础上运用沙库巴曲缬沙坦进行治疗,治疗后,对比两组治疗患者的治疗效果、不良反应状况以及生活质量。结果观察组患者治疗效果及生活质量显著高于对照组,不良反应发生率显著低于对照组,差异有统计学意义(P<0.05)。结论在慢性心力衰竭患者中运用沙库巴曲缬沙坦与比索洛尔联合治疗后,能够有效提升患者的治疗效果,降低患者不良反应发生率,改善患者生活质量,效果显著,可推广。

Objective To investigate the clinical effect of sakubatroxol valsartan combined with bisoprolol in the treatment of chronic heart failure.Methods 80 patients with chronic heart failure who were treated in our hospital from January 2017 to August 2018 were selected as the research subjects,and they were divided into control group and observation group by clinical random lottery,with 40 cases in each group.The patients in the control group were treated with bisoprolol,while those in the observation group were treated with sakubatroxol and valsartan on the basis of the patients in the control group.After the treatment,the therapeutic effect,adverse reactions and quality of life of the patients in the two groups were compared.Results After treatments,the curative effect and quality of life of the patients in the observation group were significantly higher than those in the control group,and the incidence of adverse reactions was significantly lower than those in the control group(P<0.05).Conclusion The combined treatment of Sakubatra,Valsartan and Bisoprolol in patients with chronic heart failure can effectively improve the therapeutic effect,reduce the incidence of adverse reactions and improve the quality of life of patients.The effect is remarkable and can be popularized.